Background: Ovarian cancer is the second most common malignancy of the female reproductive system and one of the leading lethal gynecologic malignancies. Screening of ovarian cancer in certain high risk groups is very important due to unspecificity and late appearance of symptoms. Its risk factors include positive family history, older age of menopause and low parity as pregnancy protects against ovarian cancer. Objectives: to compare the accuracy of preoperative prediction of malignancy in ovarian mass by morphological ultrasound (US) examination, Doppler indices and CA 125 serum level with the result of histopathological examination mass after laparotomy. Methods: One hundred and four cases of ovarian masses predicted to be malignant by US examination and CA 125 serum level were subjected to laparotomy and histopathological examination. The main outcome measures in the ovarian masses were: a-the US signs of malignancy [ such as solid mass, multiple septation in cystic mass, mixed solid and cystic components, thick cyst wall (> 3 mm), nodule in a cyst wall ] , b-Doppler indices(resistance index and pulsatility index) , c-CA125 serum level, and d-histopathological examination findings after laparotomy. Results: The histopathology identified 20 benign (B) and 84 malignant (M) ovarian masses. The benign tumors were 9(45%) endometroitic cyst, 6(30%) pseudomucinous cyst adenoma and 5(25%) serous cyst adenoma. The malignant ones included 43(51.2%) papillary serous cyst adenocarcinoma 18(21.4%) endometrioid adenocarcinoma , 10(11.9%) pseudomucinous cyst adenocarcinoma, 5(5.9%) clear cell adenocarcinoma, 2(2.4%) papillary serous borderline cyst adenocarcinoma, 2(2.4%) borderline serous adenocarcinoma, 1(1.2%) serous adenocarcinoma, 1(1.2%) borderline endometroid adenocarcinoma, 1(1.2%) dysgerminoma and 1(1.2%) Pseudomucinous borderline cyst adenocarcinoma]. The US showed no morphological signs of malignancy in 10 [9.6% (9 M vs. . 1 B) ] masses. Doppler studies of ovarian mass vasculature showed that < 0.4 resistance index and < 1 pulsatility index prevailed significantly in 83 and 82 malignant masses respectively (P< 0.001) while CA125 serum cutoff level 30 IU/ ml alone failed to differentiate between the benign and malignant masses Conclusion: using CA125 serum cutoff level 30 IU/ ml combined with US grey scale or color Doppler examination can discriminate between benign and malignant adnexal masses especially in positive Doppler indices.
INTRODUCTION
Ovarian cancer (OC) is the second most common malignancy of the female reproductive system and one of the leading causes of death among gynaecologic malignancies. (1) The disease is more common in industrialized nations, with the exception of Japan. In the United States, females have 1 % to 2.5% (1 out of 40-60 women) lifetime chance of developing OC. Older women are at highest risk. More than half of the deaths from OC occur in women between 55 and 74 years of age and approximately one quarter of OC deaths occur in women between 35 and 54 years of age. (2) There are no statistics that describe disease incidence in Egypt. Signs and symptoms of OC are frequently absent early and when they exist they may be subtle.
In most cases, the symptoms persist for several months before being recognized and diagnosed. (3) The five-year survival rate for all stages of OC is 47%. (4) For cases where a diagnosis is made early in the disease, when the cancer is still confined to the primary site, the five-year survival rate is 92.7 %. (5) So prognosis is good for women diagnosed at an early stage, whereas the majority, diagnosed at later stages, is likely to survive less than 5 years. (6) Symptoms as bloating, fullness, and pressure in the abdomen are the most prominent symptoms. Pain and fatigue are also important, followed by problems in urination and constipation. ( (9, 20) Studies exploring the value of screening those women for OC are lacking and urgently required. Even though population-based screening for OC is not recommended, and although there is no level of evidence that this group of women should undergo screening, it seems prudent that, until evidence is available, measurement of CA 125 levels and transvaginal ultrasound should be undertaken at least on yearly basis. (21) CA125 is still the most extensively studied biomarker for possible use in the early detection of OC, and has proved valuable in both detection and disease monitoring. (23, 24) CA125 is elevated in the serum of most (25) and in the majority of women with occult cancers identified at prophylactic surgery. (26) Using (27, 28, 29) .
Objectives:
To evaluate the accuracy of preoperative prediction of malignancy in ovarian mass by the morphological ultrasound examination, Doppler indices and CA 125 serum level. Table ( 3) showed that by using ultrasound alone, the ultrasonographic morphological signs of malignancies were respectively seen in 75 (89.3%) and 19 (95%) malignant and benign masses with no significant difference in-between (p=0.58) Receiver operating characteristics ( ROC ) Curve 
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